These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22748194)

  • 41. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between serum concentration of cardiac troponin I in chronic renal failure patients and cardiovascular events.
    Vichairuangthum K; Leowattana W; Ong-Ajyooth L; Pokum S
    J Med Assoc Thai; 2006 May; 89(5):714-20. PubMed ID: 16756060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
    Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
    Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.
    Pascual-Figal DA; Manzano-Fernández S; Boronat M; Casas T; Garrido IP; Bonaque JC; Pastor-Perez F; Valdés M; Januzzi JL
    Eur J Heart Fail; 2011 Jul; 13(7):718-25. PubMed ID: 21551163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Natriuretic peptides as cardiac markers in clinical practice].
    Veien KT; Jensen JK; Hildebrandt P; Gøtze JP; Nielsen OW; Køber L
    Ugeskr Laeger; 2010 Jul; 172(30):2111-6. PubMed ID: 20654278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac natriuretic peptides for cardiac health.
    Rademaker MT; Richards AM
    Clin Sci (Lond); 2005 Jan; 108(1):23-36. PubMed ID: 15476436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natriuretic peptides.
    Daniels LB; Maisel AS
    J Am Coll Cardiol; 2007 Dec; 50(25):2357-68. PubMed ID: 18154959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac troponin levels in heart failure.
    Potluri S; Ventura HO; Mulumudi M; Mehra MR
    Cardiol Rev; 2004; 12(1):21-5. PubMed ID: 14667259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [B-type natriuretic hormone--diagnostic and prognostic cardiovascular biomarker].
    Lengyel M
    Orv Hetil; 2007 Feb; 148(5):217-21. PubMed ID: 17344142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
    Rubin C; Nolin TD; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases.
    Battistoni A; Rubattu S; Volpe M
    Int J Cardiol; 2012 May; 157(2):160-8. PubMed ID: 21763018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain natriuretic peptide (BNP): a new risk marker in hemodialysis patients?
    Jorge S; Lopes JA; Neves F; Gomes da Costa A; Prata MM
    South Med J; 2008 Nov; 101(11):1083. PubMed ID: 19088509
    [No Abstract]   [Full Text] [Related]  

  • 57. [Brain natriuretic peptide might predict the abnormal geometry of heart in children with chronic kidney disease].
    Hedvig J; Podracká L; Potoceková D
    Cas Lek Cesk; 2008; 147(2):90-5. PubMed ID: 18383959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of cardiac biomarkers in cardiovascular disease risk assessment.
    Collinson P
    Curr Opin Cardiol; 2014 Jul; 29(4):366-71. PubMed ID: 24848409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Value of biological markers in cardiovascular disease].
    Couderc R; Lefevre G; Fiessinger JN
    Bull Acad Natl Med; 2012 Jan; 196(1):217-22. PubMed ID: 23259345
    [No Abstract]   [Full Text] [Related]  

  • 60. B-type natriuretic peptide in rheumatic diseases: a cardiac biomarker or a sophisticated acute phase reactant?
    Dimitroulas T; Giannakoulas G; Karvounis H; Garyfallos A; Settas L; Kitas G
    Autoimmun Rev; 2012 Oct; 11(12):837-43. PubMed ID: 22401930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.